Skip to content

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

Effect of Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00499148
Enrollment
59
Registered
2007-07-11
Start date
2006-08-31
Completion date
2007-10-31
Last updated
2010-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

The purpose of the study was to evaluate the effect of an herbal extract on postprandial glycemia following a meal.

Interventions

OTHERherbal extract; root of woody shrub grown in India/Sri-Lanka

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* type 2 diabetes * Between 18 and 75 years of age * Male or non-pregnant, non-lactating female, at least 6 weeks postpartum * If of childbearing potential, is practicing birth control * BMI is more than or equal to 18kg/m2 and less than or equal to 35kg/m2 * If on anti-hyperglycemic, anti-hypertensive, lipid-lowering, or thyroid medications or hormone therapy, has been on constant dosage for at least 3 months prior to screening visit

Exclusion criteria

* Uses insulin for glucose control or has type 1 diabetes * History of diabetic ketoacidosis. * Current infection; surgery or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks. * Active malignancy * Significant cardiovascular event less than or equal to 6 months prior to screening visit or history of congestive heart failure * End state organ failure or status post organ transplant * History of renal disease * Current hepatic disease * History of severe gastroparesis * Has a chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV * Currently taking herbals, dietary supplements, or medications, other than anti-hyperglycemic medications, during the past 4 weeks that could profoundly affect blood glucose * Clotting or bleeding disorders * Allergic or intolerant to any ingredient found in the study products

Design outcomes

Primary

MeasureTime frame
positive AUC for plasma glucose4 hours

Secondary

MeasureTime frame
positive AUC for serum insulin; adjusted peak values for plasma glucose and serum insulin; baseline plasma glucose and serum insulin concentrations; adjusted values for plasma glucose and serum insulin at individual postprandial time points.4 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026